Tempest Therapeutics announces exercise of 1,172,414 warrants at reduced $1.73 per share price

Tempest Therapeutics, Inc.

TPST

0.00

Tempest Therapeutics set a deal for immediate cash exercise of warrants for 1,172,414 shares at USD 1.73, cut from USD 3.5.
Gross proceeds expected at about USD 2 million; closing expected on or about May 29, 2025.
Will issue new unregistered short-term warrants for up to 2,344,828 shares at USD 1.73; exercisable only after stockholder approval.
New short-term warrants expire two years from issuance; full cash exercise could raise about USD 4 million.
Shares from the existing warrant exercise are registered for resale on an effective Form S-1.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempest Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605290800PRIMZONEFULLFEED9728665) on May 29, 2026, and is solely responsible for the information contained therein.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.